biotech

Kumquat Biosciences Inc.

Account opportunity

Not established

Relationship

Active signals

Trials as sponsor

Why this account matters

Kumquat Biosciences Inc.

New trial — A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

New trialNCT07542704

53/100

Opportunity

Commercial fit11/25

Clinical timing20/20

Biomarker need5/20

Relationship2/10

Signal strength9/10

Account value5/10

Urgency1/5

New phase 1 trial NCT07542704 posted by Kumquat Biosciences Inc.: "A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies". New trial on a phase 1 not yet recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 140 days ago.

ConfidenceHigh · 87%clinical development · translational medicine · clinical operations

Draft outreach Review

NextHold. Score is below the tenant threshold (55). Keep on the watchlist for follow-on signals.

Kumquat Biosciences Inc.

New trial — A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

New trialNCT07207707

53/100

Opportunity

Commercial fit11/25

Clinical timing20/20

Biomarker need5/20

Relationship2/10

Signal strength9/10

Account value5/10

Urgency1/5

New phase 1 trial NCT07207707 posted by Kumquat Biosciences Inc.: "A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies". New trial on a phase 1 recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 111 days ago.

ConfidenceHigh · 87%clinical development · translational medicine · clinical operations

Draft outreach Review

NextHold. Score is below the tenant threshold (55). Keep on the watchlist for follow-on signals.

Trials

Trial	Phase	Testing language
NCT07207707 A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies	phase 1	mol. elig.
NCT07542704 A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies	phase 1	mol. elig.